These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9126880)

  • 21. [Effect of thromboxane A2 synthetase inhibitor (OKY-046) on leukotriene C4-induced airway hyperresponsiveness in guinea pigs].
    Tsukagoshi H; Yodonawa S; Kurosawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jun; 31(6):707-11. PubMed ID: 8345703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs.
    Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ozagrel a thromboxane A2 synthase inhibitor extenuates endothelial dysfunction, oxidative stress and neuroinflammation in rat model of bilateral common carotid artery occlusion induced vascular dementia.
    Bhatia P; Kaur G; Singh N
    Vascul Pharmacol; 2021 Apr; 137():106827. PubMed ID: 33346090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ozagrel (OKY-046), a thromboxane synthetase inhibitor, on theophylline pharmacokinetics in asthmatic patients.
    Kawakatsu K; Kino T; Yasuba H; Kawaguchi H; Tsubata R; Satake N; Oshima S
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):158-63. PubMed ID: 2338368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors Dazoxiben and Ozagrel.
    Sathler PC; Santana M; Lourenço AL; Rodrigues CR; Abreu P; Cabral LM; Castro HC
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):527-31. PubMed ID: 23914925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of thromboxane A2 synthetase inhibitors in the treatment of patients with bronchial asthma.
    Kurosawa M
    Clin Ther; 1995; 17(1):2-11; discussion 1. PubMed ID: 7758058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlative alteration of thromboxane A2 with antigen-induced bronchoconstriction and the role of platelets as a source of TXA2 synthesis in guinea pigs: effect of DP-1904, an inhibitor of thromboxane synthetase.
    Takami M; Tsukada W
    Pharmacol Res; 1998 Aug; 38(2):133-9. PubMed ID: 9721601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ameliorative effect of ozagrel, a thromboxane A2 synthase inhibitor, in hyperhomocysteinemia-induced experimental vascular cognitive impairment and dementia.
    Bhatia P; Singh N
    Fundam Clin Pharmacol; 2021 Aug; 35(4):650-666. PubMed ID: 33020931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theophylline in the inhibition of angiotensin-converting enzyme inhibitor-induced cough.
    Cazzola M; Matera MG; Liccardi G; De Prisco F; D'Amato G; Rossi F
    Respiration; 1993; 60(4):212-5. PubMed ID: 8265877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
    de Chaffoy de Courcelles D; De Clerck F
    Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ozagrel, a selective thromboxane A2-synthetase inhibitor, on cerebral infarction in rats. Comparative study with norphenazone, a free-radical scavenger.
    Imamura T; Kiguchi S; Kobayashi K; Ichikawa K; Yamazaki Y; Kojima M
    Arzneimittelforschung; 2003; 53(10):688-94. PubMed ID: 14650360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial effect of CV-4151 (Isbogrel), a thromboxane A2 synthase inhibitor, in a rat middle cerebral artery thrombosis model.
    Imura Y; Kiyota Y; Nagai Y; Nishikawa K; Terashita Z
    Thromb Res; 1995 Jul; 79(1):95-107. PubMed ID: 7495108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and pharmacodynamic studies of a thromboxane synthetase inhibitor, ozagrel, in rabbits.
    Zheng NX; Sato H; Adachi I; Kanamoto I; Horikoshi I
    Biol Pharm Bull; 1995 Dec; 18(12):1738-43. PubMed ID: 8787798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ozagrel for Patients With Noncardioembolic Ischemic Stroke: A Propensity Score-Matched Analysis.
    Wada T; Yasunaga H; Horiguchi H; Fushimi K; Matsubara T; Nakajima S; Yahagi N
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2828-2837. PubMed ID: 27567296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines.
    Dicpinigaitis PV
    Chest; 2006 Jan; 129(1 Suppl):169S-173S. PubMed ID: 16428706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of antigen-induced airway hyperresponsiveness in rats: effects of ozagrel (a thromboxane A2 synthase inhibitor) and of CV-3988 (a platelet activating factor antagonist).
    Misawa M; Chiba Y
    Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):341-9. PubMed ID: 7938906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of thromboxane A2 synthetase inhibitor, OKY-046, on sputum in chronic bronchitis and diffuse panbronchiolitis.
    Kurashima K; Fujimura M; Hoyano Y; Takemura K; Matsuda T
    Eur Respir J; 1995 Oct; 8(10):1705-11. PubMed ID: 8586126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The relationship between polymorphism of angiotensin converting enzyme gene and cough caused by angiotensin converting enzyme inhibitors].
    Yang SM; He QY; Miao YD
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Apr; 26(4):203-5. PubMed ID: 12901825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered prostaglandin metabolism induced by angiotensin-converting enzyme inhibitors in broncho-alveolar lavage fluid of the guinea pig.
    Umemura K; Wada K; Suzuki Y; Nishiyama H; Nakashima M
    Jpn J Pharmacol; 1996 Sep; 72(1):17-21. PubMed ID: 8902595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A prospective study on the cough mechanism induced by angiotensin-converting enzyme inhibitors in patients with hypertension].
    Ye RJ; He QY; Gai J; Shang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):581-4. PubMed ID: 15498266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.